Translumina

Exploring Limitless Possibilities for Life

Since 2010, Translumina Therapeutics has been dedicated to transforming the landscape of coronary care. As a pioneering company in the manufacture and distribution of coronary intervention devices, we believe in the mission of “Exploring Limitless Possibilities for Life.”

At Translumina Therapeutics, we specialize in producing best-in-class drug-eluting stents that set the benchmark for quality and performance in the market. Our commitment to excellence extends beyond manufacturing; we take pride in introducing cutting-edge technologies for coronary intervention procedures to the Indian market, ensuring that advanced medical solutions are accessible where they are needed most.

Our journey is fueled by innovation and a passion for improving lives. We are driven by core values that emphasize integrity, quality, and continuous improvement. Each device we create is a testament to our dedication to saving lives and enhancing the quality of care for patients with coronary artery diseases.

We are more than just a medical device company; we are a partner in the healthcare community, working alongside healthcare providers, hospitals, and clinics to deliver life-saving technologies. Our vision is to continue breaking barriers in medical technology, expanding the horizons of what is possible in coronary care.
Join us in our mission to make “Limitless Possibilities for Life” a reality. Together, we can make a difference, one heartbeat at a time.

Executive Leadership

Board of Directors

Gurmit Singh Chugh

Gurmit Singh Chugh

Co-Founder and Chairman

Punita Sharma Arora

Punita Sharma Arora

Co-Founder and Vice Chairman

Avnish Mehra

Avnish Mehra

Vice Chairman, Private Equity – Everstone Capital

Arjun Oberoi

Arjun Oberoi

Managing Director – Everstone Capital

Vishal Sharma

Vishal Sharma

Managing Director - Everstone Capital

Vishal Goenka

Vishal Goenka

Executive Director - Everstone Capital

Indranil Mukherjee

Indranil Mukherjee

Group CEO

Gurmit Singh Chugh

Gurmit Singh Chugh

Co-Founder and Chairman

Executive Leadership Team

Indranil Mukherjee

Indranil Mukherjee

Group CEO

Kewal Jindal

Kewal Jindal

Group CFO

Paritosh Arora

Paritosh Arora

CEO – India Business

Kalyan Bhowal

Kalyan Bhowal

VP – Operations, India

Satyakam Mishra

Satyakam Mishra

CHRO

Eric Kumpa

Eric Kumpa

MD – Translumina Gmbh

Michael Stöver

Michael Stöver

Global Head – R&D

Ingrid Frank

Ingrid Frank

CEO – LaMed Gmbh

Our Journey of Medical Innovation
and Global Expansion

Translumina journey reflects a steadfast commitment to advancing medical technology and transforming patient care worldwide. With an expanding portfolio of innovative cardiovascular devices and a strong global presence, we build on India’s healthcare heritage while contributing to medical progress across continents. Our collaboration with the German Heart Centre exemplifies our dedication to pioneering advancements in cardiovascular care, setting benchmarks for quality and excellence in patient outcomes.

Translumina
Incorported

2010

Launch of
YUKON DES technology

2011

Collaborated with ASAHI Intecc, Japan

2014

Launched Complete portfolio for Vascular Access solutions

2016

Partnered with
Kaneka, Japan

2017

Launched VIVO ISAR, World’s First
Polymer Free Dual Drug DES

World’s First Ultra High Pressure Balloon OPN NC, SIS Medical, Switzerland

Partenered with IMPELLA, Abiomed, USA

2018

Acquired Translumina
GmbH, Germany

Acquired Artic GmbH,
Germany & Partnership with
Everstone Capital, Singapore

2019

Launched Shockwave IVL, USA

2020

Asia’s largest laser cutting facility in Dehradun

2021

Asia’s largest manufacturing facility for Heart Valves in AMTZ,Vizag

Launch of ISAR SUMMIT
Everolimus Eluting Polymer free DES

2022

Imaging Solutions with
ACIST, USA

2023

Direct Operations in UAE
Translumina

2024

Group Companies

Translumina is strengthened by its association with Lamed Healthcare and Blue Medical Devices, both leaders in their respective fields. With over 30 years of expertise, Lamed focuses on high-quality, scientifically proven innovations, particularly in vascular and cardiac surgery and stent grafts, striving for impactful advancements in healthcare. Blue Medical, based in the Netherlands, specializes in advanced drug-coated balloon technologies for complex coronary interventions, enhancing safety and efficacy in cardiovascular treatments. Together, our group companies embody a shared commitment to quality, innovation, and global healthcare solutions.

Type and press enter to search